Log in to your Inderes Free account to see all free content on this page.
BioArctic
302.40 SEK
-1.43 %
Less than 1K followers
BIOA B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for BioArctic
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 76.6 | 101.2 | 257.4 | 1,289.6 | 392.1 | 133.3 | 184.0 | 1,999.1 |
| EBITDA | 0.3 | -35.9 | -171.1 | 1,078.4 | 182.2 | -25.4 | 36.4 | 1,271.6 |
| EBIT | -26.1 | -53.5 | -228.5 | 1,075.3 | 179.1 | -28.8 | 33.2 | 1,258.8 |
| EBIT-% | -34.0 % | -52.8 % | -88.8 % | 83.4 % | 45.7 % | -21.6 % | 18.1 % | 63.0 % |
| Profit before taxes | -19.7 | -43.9 | -189.5 | 1,066.0 | 171.5 | -20.9 | 39.1 | 1,255.6 |
| Net income | -19.6 | -31.5 | -177.1 | 1,021.5 | 96.6 | -86.9 | -8.8 | 1,022.3 |
Login required
This content is only available for logged in users